A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Researchers at The Hospital for Sick Children (SickKids) have developed a novel antibody platform that enhances the targeting abilities of antibodies to combat SARS-CoV-2 variants. Leveraging the Multabody platform, co-developed by SickKids [...]